VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

HeV-sG-V
Vaccine Information
  • Vaccine Name: HeV-sG-V
  • Target Pathogen: Nipah virus
  • Target Disease: Nipah virus disease
  • Type: Subunit vaccine
  • Status: Licensed
  • Host Species for Licensed Use: Human
  • Antigen: HeV-sG recombinant antigen(Geisbert et al., 2021)
  • Preparation: P1 stock was obtained from CDC, p2 stock was prepared in Vero E6 cells and stored at University of Texas Medical Branch (UTMB) on 30 May 2011. The virus is stored at −80 °C, tested negative for mycoplasma and endotoxin.(Geisbert et al., 2021)
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: The virus is stored at −80 °C
Host Response
References